Schonfeld Strategic Advisors LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Schonfeld Strategic Advisors LLC

$15.4 Billion
Q4 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 632,214 shares of ARWR stock, worth $12.6 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

632,214

Previous 387,687 63.07%

Holding current value

$12.6 Million

Previous $7.51 Million 58.36%

% of portfolio

0.08%

Previous 0.05%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$17.7 - $26.34 $4.33 Million - $6.44 Million	244,527 Added 63.07%	632,214 $11.9 Million
Q3 2024 Nov 14, 2024	SELL	$19.36 - $29.54 $439,839 - $671,119	-22,719 Reduced 5.54%	387,687 $7.51 Million
Q2 2024 Aug 14, 2024	SELL	$21.87 - $28.24 $117,594 - $151,846	-5,377 Reduced 1.29%	410,406 $10.7 Million
Q1 2024 May 15, 2024	SELL	$27.21 - $39.48 $1.21 Million - $1.76 Million	-44,494 Reduced 9.67%	415,783 $11.9 Million
Q4 2023 Feb 14, 2024	BUY	$21.2 - $31.03 $9.76 Million - $14.3 Million	460,277 New	460,277 $14.1 Million
Q2 2023 Aug 14, 2023	BUY	$25.16 - $41.38 $564,691 - $928,732	22,444 New	22,444 $800,000
Q4 2022 Feb 14, 2023	SELL	$28.0 - $40.56 $787,416 - $1.14 Million	-28,122 Reduced 61.91%	17,300 $701,000
Q3 2022 Nov 14, 2022	BUY	$29.63 - $48.31 $1.04 Million - $1.69 Million	35,061 Added 338.39%	45,422 $1.5 Million
Q2 2022 Aug 15, 2022	SELL	$27.79 - $50.61 $201,171 - $366,365	-7,239 Reduced 41.13%	10,361 $365,000
Q1 2022 May 16, 2022	SELL	$39.62 - $69.97 $47,028 - $83,054	-1,187 Reduced 6.32%	17,600 $809,000
Q4 2021 Feb 14, 2022	BUY	$58.09 - $82.51 $1.09 Million - $1.55 Million	18,787 New	18,787 $1.25 Million
Q3 2021 Nov 16, 2021	SELL	$58.38 - $84.96 $1.11 Million - $1.61 Million	-18,996 Closed	0 $0
Q2 2021 Nov 16, 2021	SELL	$62.15 - $90.32 $192,665 - $279,992	-3,100 Reduced 14.03%	18,996 $1.57 Million
Q2 2021 Aug 16, 2021	BUY	$62.15 - $90.32 $1.14 Million - $1.65 Million	18,295 Added 481.32%	22,096 $1.83 Million
Q1 2021 May 17, 2021	SELL	$61.35 - $90.47 $706,752 - $1.04 Million	-11,520 Reduced 75.19%	3,801 $252,000
Q4 2020 Feb 16, 2021	SELL	$43.82 - $85.37 $698,052 - $1.36 Million	-15,930 Reduced 50.97%	15,321 $1.18 Million
Q3 2020 Nov 16, 2020	BUY	$33.21 - $51.27 $1.04 Million - $1.6 Million	31,251 New	31,251 $1,000
Q3 2018 Nov 14, 2018	SELL	$14.0 - $20.3 $1.15 Million - $1.66 Million	-81,900 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$6.37 - $14.02 $93,275 - $205,294	14,643 Added 21.77%	81,900 $1.11 Million
Q1 2018 May 15, 2018	BUY	$3.72 - $7.64 $250,196 - $513,843	67,257 New	67,257 $485,000

Others Institutions Holding ARWR

# of Institutions

304

Shares Held

96.2M

Call Options Held

388K

Put Options Held

420K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.11B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC Arrowhead Pharmaceuticals, Inc. Transaction History